Authors


Co.

Latest:

A new way to look at the performance of passive cold-chain shipping containers

A 'performance curve' chart for containers could simplify the design process


Charles T. Bennett, Health

Latest:

HPCLC Spring Meeting recap

Logistics managers in life sciences and personal care focus on transportation capacity


John DiPalo, Acsis, Inc.

Latest:

Take an enterprise view on serialization

Real business value arises from going beyond simple regulatory compliance for California's e-pedigree mandate


Karen Ribler, Center for Healthcare Supply Chain Research

Latest:

How REMS Affect Pharmaceutical Distribution Processes and Partners

First-ever study of the impact of REMS on supply chains finds that collaboration is a critical requirement


Jane Reed

Latest:

Adverse event reporting: NLP's new niche?

The emergence of natural language processing in pharmacovigilance


Yin Ho

Latest:

A case study in differing approaches to reimbursement approval in Europe and the US

Looking at 'cost' and 'value' under different evaluation processes


Peter Seidl, Schreiner MediPharm

Latest:

The role of labels in patient safety

Advanced label technologies serve functions far beyond product identification



Matt Adkins, Simon-Kucher & Partners

Latest:

Medicare Star ratings: the billion-dollar opportunity for providers

New incentives for health plans could alter the way payers review new drugs



Sharon Suchotliff, ZS Associates

Latest:

Accelerating the drive toward patient centricity

Getting away from the traditional product-centric management structure is not easy; here’s how to do it


Terry Bernacchi

Latest:

Emerging Payer Business Trends That Pharmacos Need to Know

Drivers in the post-healthcare-reform world


Fred Baumann, JDA Software

Latest:

The right supply chain prescription

While pharma manufacturers may be concerned about the impact of item-level inventory tracking, it's an idea that actually makes great business sense


By Stewart H. Rosen, M.D.

Latest:

The growing role of clinical trial educators

Addressing patient recruitment and retention issues is a natural role for CTEs


Michael Swanick, PwC

Latest:

Top health industry issues for life sciences in 2014

PwC's annual forecast of the year's most important healthcare trends


Kevin McPherson, GENCO Healthcare

Latest:

Managing logistics partnerships in uncertain times

Outsourced services can provide significant financial and risk-avoidance benefits


Rachel Sherman, MD, MPH, US Food

Latest:

Laying the foundation for a national system for evidence generation

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis


By Marrie Groeneveld, SkyCell

Latest:

Big Data in pharma cold chain logistics

Collecting and reporting data in near real time cuts costs and reduces risk


By David Hileman, PharmaCord

Latest:

New approaches to specialty distribution

A direct-distribution model could save expense for payers and patients while providing better service



By Rob Lien

Latest:

Navigating the patient journey after rare disease diagnosis

Commercial teams can prepare for overcoming predictable hurdles


Marcelo Sicoli, EnterBrazil

Latest:

Entering the Brazilian Pharmaceutical Market

Stable economics and growing healthcare concerns make Brazil one of the top emerging markets, with a current growth rate >20%


Steven Anderson, NACDS

Latest:

Retail Pharmacies and the Health and Wellness Renaissance

Following are excerpts from the keynote presentation of Steven C. Anderson, president and CEO of the National Assn. of Chain Drug Stores, at its annual meeting, Palm Beach, FL, Apr. 25.


Edward Fotsch, MD, PDR Network

Latest:

Get Ready for EHRs as the Essential Communications Platform for Pharma

Electronic health-record systems (EHRs) are bringing needed drug information to the point of care for prescribers


Anne Runyan, Two Labs Pharma Services

Latest:

Innovative models to address cell- and gene-therapy (CGT) payer challenges

Carving out CGTs for payment systems involving government intervention may be an answer


Glenn Snyder, Deloitte Consulting LLP

Latest:

Understanding the companion-diagnostics environment

While the pharma industry is growing more dependent on companion diagnostics, test developers face an uncertain business model


Jon Ragati, Sparta Systems

Latest:

How cloud-based IT systems address FDA validation requirements

Paper validation records will disappear in the face of continuous validation


Richard J. Tinsley, Putnam Associates

Latest:

How to Think About Companion Diagnostics

Both promise and peril exist for drugmakers in working with diagnostic tests to commercialize new medications or refine the applicability of existing ones


By Alan Kennedy, Executive Director, Team-Up

Latest:

A new approach to pharma supply-chain collaboration

Team-Up seeks to bring manufacturers and logistics providers together


Michael Bonney, CEO, Cubist Pharmaceuticals

Latest:

Bringing New Science, and New Partners, Into the Drug Development Process

Today’s evolving healthcare environment calls for more collaboration in bringing drugs to market

© 2024 MJH Life Sciences

All rights reserved.